← FDA Drug Approvals (Drugs@FDA)
ANDA213499
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM CO LTD · Approved 2025-10-08
Drug application
- FDA Application #
ANDA213499
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- —
- Generic name
- —
- Active ingredients
- —
- Dosage form
- —
- Route
- —
- Marketing status
- —
- Sponsor
- QILU PHARM CO LTD
- First approval
- 2025-10-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown